JP2024517473A5 - - Google Patents
Info
- Publication number
- JP2024517473A5 JP2024517473A5 JP2023569836A JP2023569836A JP2024517473A5 JP 2024517473 A5 JP2024517473 A5 JP 2024517473A5 JP 2023569836 A JP2023569836 A JP 2023569836A JP 2023569836 A JP2023569836 A JP 2023569836A JP 2024517473 A5 JP2024517473 A5 JP 2024517473A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- independently
- group
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187226P | 2021-05-11 | 2021-05-11 | |
| US63/187,226 | 2021-05-11 | ||
| PCT/US2022/028736 WO2022240966A1 (en) | 2021-05-11 | 2022-05-11 | Compounds and methods for yap/tead modulation and indications therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517473A JP2024517473A (ja) | 2024-04-22 |
| JP2024517473A5 true JP2024517473A5 (cg-RX-API-DMAC10.html) | 2025-05-13 |
Family
ID=84029441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569836A Pending JP2024517473A (ja) | 2021-05-11 | 2022-05-11 | Ｙａｐ／ｔｅａｄの調節のための化合物及び方法ならびにそれらの適用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240174659A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4337207A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024517473A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117956996A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022272302A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3177022A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022240966A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023211607A1 (en) * | 2022-01-28 | 2024-08-22 | Opna Bio SA | Compounds and methods for yap/tead modulation and indications therefor |
| CN119968359A (zh) | 2022-09-29 | 2025-05-09 | 英矽智能科技知识产权有限公司 | Tead抑制剂及其使用方法 |
| EP4654969A1 (en) * | 2023-01-27 | 2025-12-03 | Opna Bio SA | Compounds and methods for yap/tead modulation and indications therefor |
| WO2024159081A1 (en) * | 2023-01-27 | 2024-08-02 | Opna Bio SA | Compounds and methods for yap/tead modulation and indications therefor |
| WO2024159088A1 (en) * | 2023-01-27 | 2024-08-02 | Opna Bio SA | Compounds and methods for yap/tead modulation and indications therefor |
| EP4654970A1 (en) * | 2023-01-27 | 2025-12-03 | Opna Bio SA | Compounds and methods for yap/tead modulation and indications therefor |
| CN118255693A (zh) * | 2024-03-28 | 2024-06-28 | 大连理工大学 | 联苯类化合物及其在制备治疗白血病、肺癌以及乳腺癌药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1573212A (en) | 1976-04-15 | 1980-08-20 | Technicon Instr | Immunoassay for gentamicin |
| US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
| US4626513A (en) | 1983-11-10 | 1986-12-02 | Massachusetts General Hospital | Method and apparatus for ligand detection |
| EP0154734B1 (en) | 1984-03-15 | 1990-08-29 | Immunex Corporation | Immediate ligand detection assay, a test kit and its formation |
| KR20140070676A (ko) | 2002-09-06 | 2014-06-10 | 인설트 테라페틱스, 인코퍼레이티드 | 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체 |
| US7544699B2 (en) * | 2003-08-08 | 2009-06-09 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
| WO2008022467A1 (en) * | 2006-08-25 | 2008-02-28 | Mark Lautens | 2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof |
| CA2730208C (en) * | 2008-07-25 | 2016-10-25 | Boehringer Ingelheim International Gmbh | 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use |
| WO2015078417A1 (zh) * | 2013-11-29 | 2015-06-04 | 四川好医生药业集团有限公司 | 吡咯并嘧啶化合物及其在制备降血糖药物中的用途 |
| US10670605B2 (en) * | 2015-10-22 | 2020-06-02 | The Scripps Research Institute | Cysteine reactive probes and uses thereof |
| EP3877356A4 (en) * | 2018-11-09 | 2022-06-22 | Vivace Therapeutics, Inc. | BICYCLIC LINKS |
| WO2020191151A1 (en) * | 2019-03-19 | 2020-09-24 | Oncovalent Therapeutics Inc. | Sumo inhibitor compounds and uses thereof |
| AU2020257207B2 (en) * | 2019-04-16 | 2026-06-04 | Vivace Therapeutics, Inc. | Bicyclic compounds |
-
2022
- 2022-05-11 CN CN202280048076.4A patent/CN117956996A/zh active Pending
- 2022-05-11 CA CA3177022A patent/CA3177022A1/en active Pending
- 2022-05-11 EP EP22808253.3A patent/EP4337207A4/en active Pending
- 2022-05-11 JP JP2023569836A patent/JP2024517473A/ja active Pending
- 2022-05-11 AU AU2022272302A patent/AU2022272302A1/en not_active Abandoned
- 2022-05-11 WO PCT/US2022/028736 patent/WO2022240966A1/en not_active Ceased
-
2023
- 2023-11-09 US US18/505,538 patent/US20240174659A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025503945A5 (cg-RX-API-DMAC10.html) | ||
| JP2019512505A5 (cg-RX-API-DMAC10.html) | ||
| AU2020266592B2 (en) | Substituted cyclolakyls as modulators of the integrated stress pathway | |
| JP2022528780A5 (cg-RX-API-DMAC10.html) | ||
| JP2015510944A5 (cg-RX-API-DMAC10.html) | ||
| JP2010525057A5 (cg-RX-API-DMAC10.html) | ||
| RU2018138828A (ru) | Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами | |
| RU2013145310A (ru) | Диспиропирролидиновые производные | |
| TW201806593A (zh) | 含有ｅｐ拮抗藥與免疫核查點阻礙藥而成之組合 | |
| CA3080968A1 (en) | Modulators of the integrated stress pathway | |
| JP2017533266A5 (cg-RX-API-DMAC10.html) | ||
| RU2014130125A (ru) | Новые пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| CN112204006A (zh) | 整合应激通路的调节剂 | |
| RU2011132118A (ru) | Ингибиторы axl для применения в комбинированной терапии для предотвращения, устранения или лечения метастизирующего рака | |
| RU2009148796A (ru) | Производные пиперидина/пиперазина | |
| JP2022527562A5 (cg-RX-API-DMAC10.html) | ||
| JP2023542930A5 (cg-RX-API-DMAC10.html) | ||
| JP2013503139A5 (cg-RX-API-DMAC10.html) | ||
| JP2019529419A5 (cg-RX-API-DMAC10.html) | ||
| JP2020531414A5 (cg-RX-API-DMAC10.html) | ||
| RU2016106002A (ru) | Новые индольные и пиррольные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| CN113786409A (zh) | 包含磷酸肌醇3-激酶抑制剂和第二抗增殖剂的组合物 | |
| CN111386275A (zh) | 高活性sting蛋白激动剂 | |
| JP2012518598A5 (cg-RX-API-DMAC10.html) | ||
| JP2021522197A5 (cg-RX-API-DMAC10.html) |